ADHERENCE AND PERSISTENCE AMONG HEREDITARY ANGIOEDEMA PATIENTS TREATED WITH BEROTRALSTAT, LANADELUMAB, AND SUBCUTANEOUS PLASMA-DERIVED C1-INHIBITOR

Autor: Zuraw, B., Lopez-Gonzalez, L., Winer, I., Dean, A., Manjelievskaia, J., Nestler-Parr, S., Gillard, P., Christiansen, S.
Zdroj: In Annals of Allergy, Asthma & Immunology November 2024 133(6) Supplement:S25-S25
Databáze: ScienceDirect